Human Placentas and the Changing Face of Reproductive Toxicology Testing

Abstract

Pharmaceuticals are in use by 40-98% of pregnant mothers in the developed world, varying by country. There is a significant potential for obstetricians to further maintain medical prescriptions for chronic diseases during pregnancy, provided there is confidence within the pharmaceutical industry on the safety of their products. The safety of medicinal products incurs several socioeconomic challenges, and the protection of maternal and fetal health is a foremost and top priority.